intensity, and duration of the pain sensation were considered a passive reflection of the qualities of the periphDynorphin is an endogenous ligand for the opiate eral stimulus. The nervous system was believed to esreceptor, which, along with the and ␦ receptors, is a sentially act as a hardwired telephone link, with the member of the opiate G protein-coupled receptor family.
that the DRE element is functional in both directions downstream, but not upstream, of the TATA box, suggests that it physically impedes the progress of the RNA polymerase II complex (Ledo et al., 2000) . A 32 kDa protein was isolated from a human caudate expression library using a double-stranded oligonucleotide encoding the DRE sequence as a probe (Carrion et al., 1999) . Coexpression of this protein with a reporter plasmid containing the prodynorphin promoter showed that the protein was capable of repressing basal dynorphin expression, and other reporter assays confirmed that repression is effected through the DRE site. In naming this protein, Carrion and coworkers coined the acronym DREAM because the protein binds to the DRE sequence and acts as a silencer or antagonist modulator (Carrion et al., 1999) .
DREAM binds the prodynorphin promoter as a tetramer to form the 110 kDa complex (Carrion et al., 1998 (Carrion et al., , 1999 ). DREAM's primary structure contains four calcium chelating EF-hand motifs, which site-directed mutations show bind calcium and then prevent DREAM repression of the prodynorphin promoter (Carrion et al., 1999) (Figure 1) . In neuroblastoma cell lines, however, prodynorphin de-repression is PKA mediated, a surprising finding, since DREAM does not contain any PKA phosphorylation consensus sites (Carrion et al., 1998; Carrion et al., 1999) . This apparent paradox was solved when it was found that ␣CREM and DREAM form complexes 
